In pursuance of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 ('Listing Regulations'), Skybiotech Healthcare has informed that the Board of Directors at its meeting held on Friday, November 14, 2025, to considered and approved: 1. Un-Audited Financial Results (standalone and consolidated) for the half year ended September 30, 2025 and took on record the Limited Review Report issued by the Statutory Auditors of the Company. The aforesaid Board Meeting commenced at 05:50 pm and concluded at 11:55 pm on November 14, 2025.
The above information is a part of company’s filings submitted to BSE.
